PHGDH and glioblastoma: Vice versa, we could show for the first time that PHGDH inhibition with the new small-molecule inhibitor CBR-5884 sensitises GBM cells towards the conditions of the microenvironment, including glucose deprivation and severe hypoxia (Fig. 3a, Suppl.